Research graph
References from Context-dependent roles of osteopontin in aging-related neurological disorders. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3233/jad-2011-102151
10.3233/jad-2011-102151 · External reference
10.2478/s13380-012-0028-7
10.2478/s13380-012-0028-7 · External reference
10.3389/fendo.2022.1014853
10.3389/fendo.2022.1014853 · External reference
The intracellular and secreted sides of osteopontin and their putative physiopathological roles
10.3390/ijms24032942 · 2023 · External reference
The role of osteopontin in microglia biology: current concepts and future perspectives
10.3390/biomedicines10040840 · 2022 · External reference
10.1155/2017/1879437
10.1155/2017/1879437 · External reference
10.1016/j.jneuroim.2016.09.009
10.1016/j.jneuroim.2016.09.009 · External reference
10.5607/en.2017.26.6.339
10.5607/en.2017.26.6.339 · External reference
10.1016/j.bbrc.2020.01.100
10.1016/j.bbrc.2020.01.100 · External reference
10.1016/j.celrep.2019.03.099
10.1016/j.celrep.2019.03.099 · External reference
10.1016/j.immuni.2024.01.008
10.1016/j.immuni.2024.01.008 · External reference
10.1111/acel.70378
10.1111/acel.70378 · External reference
10.1002/alz.13474
10.1002/alz.13474 · External reference
10.2174/156720507779939869
10.2174/156720507779939869 · External reference
10.3233/jad-2010-1309
10.3233/jad-2010-1309 · External reference
Elevated osteopontin levels in mild cognitive impairment and Alzheimer’s disease
2013 · External reference
10.1038/s41598-021-83601-6
10.1038/s41598-021-83601-6 · External reference
10.1002/alz.14065
10.1002/alz.14065 · External reference
10.1111/cns.70269
10.1111/cns.70269 · External reference
10.1016/j.neurobiolaging.2008.06.011
10.1016/j.neurobiolaging.2008.06.011 · External reference
10.1016/j.bbi.2017.08.019
10.1016/j.bbi.2017.08.019 · External reference
Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model
10.1084/jem.20200785 · 2020 · External reference
10.1073/pnas.2218915120
10.1073/pnas.2218915120 · External reference
10.1038/s41593-023-01257-z
10.1038/s41593-023-01257-z · External reference
10.3892/etm.2024.12749
10.3892/etm.2024.12749 · External reference
Osteopontin predicts three-month outcome in stroke patients treated by reperfusion therapies
10.3390/jcm9124028 · 2020 · External reference
10.1016/j.atherosclerosis.2021.07.010
10.1016/j.atherosclerosis.2021.07.010 · External reference
Plasma thrombin-cleaved osteopontin as a potential biomarker of acute atherothrombotic ischemic stroke
2017 · External reference
10.1016/j.brainres.2020.147170
10.1016/j.brainres.2020.147170 · External reference
Osteopontin-integrin signaling positively regulates neuroplasticity through enhancing neural autophagy in the peri-infarct area after ischemic stroke
2022 · External reference
10.1016/j.immuni.2021.04.022
10.1016/j.immuni.2021.04.022 · External reference
Osteopontin attenuates microglia-mediated neuroinflammation and blood-brain barrier damage after pontine infarction
External reference
10.1016/j.neuint.2009.08.007
10.1016/j.neuint.2009.08.007 · External reference
10.1016/j.stem.2024.03.013
10.1016/j.stem.2024.03.013 · External reference
10.1016/j.brainres.2006.08.036
10.1016/j.brainres.2006.08.036 · External reference
10.1016/j.nbd.2006.10.020
10.1016/j.nbd.2006.10.020 · External reference
10.1111/j.1471-4159.2010.06896.x
10.1111/j.1471-4159.2010.06896.x · External reference
10.1007/s00702-009-0209-x
10.1007/s00702-009-0209-x · External reference
10.1002/jnr.22813
10.1002/jnr.22813 · External reference
10.1016/j.brainres.2016.10.030
10.1016/j.brainres.2016.10.030 · External reference
10.1007/s00415-025-13190-1
10.1007/s00415-025-13190-1 · External reference
10.1186/s41073-019-0064-8 · Admitted local publication
10.1093/intimm/dxac060
10.1093/intimm/dxac060 · External reference
10.1111/imr.13081
10.1111/imr.13081 · External reference
10.1161/atvbaha.107.144824
10.1161/atvbaha.107.144824 · External reference
10.1016/0888-7543(89)90074-8
10.1016/0888-7543(89)90074-8 · External reference
10.1093/nar/17.8.3306
10.1093/nar/17.8.3306 · External reference
10.1530/joe-12-0143
10.1530/joe-12-0143 · External reference
10.1016/s0945-053x(00)00108-6
10.1016/s0945-053x(00)00108-6 · External reference
10.1242/jcs.111.9.1165
10.1242/jcs.111.9.1165 · External reference
10.1006/excr.1998.4108
10.1006/excr.1998.4108 · External reference
10.1016/s0014-5793(01)02690-4
10.1016/s0014-5793(01)02690-4 · External reference
10.1126/science.271.5248.509
10.1126/science.271.5248.509 · External reference
CD44 Variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis
1999 · External reference
10.1007/s00223-013-9698-6
10.1007/s00223-013-9698-6 · External reference
10.1021/acs.biochem.1c00050
10.1021/acs.biochem.1c00050 · External reference
10.1002/jcb.29708
10.1002/jcb.29708 · External reference
10.1042/bj20140060
10.1042/bj20140060 · External reference
10.1042/bj20050341
10.1042/bj20050341 · External reference
10.1007/s12079-011-0130-6
10.1007/s12079-011-0130-6 · External reference
10.1074/jbc.274.3.1729
10.1074/jbc.274.3.1729 · External reference
10.1016/j.bbcan.2017.02.005
10.1016/j.bbcan.2017.02.005 · External reference
10.1007/s11033-020-05867-9
10.1007/s11033-020-05867-9 · External reference
Total osteopontin and its isoform opn4 are differently expressed in respiratory samples during influenza A(H1N1)pdm09 infection and progression
10.3390/microorganisms11051349 · 2023 · External reference
10.1073/pnas.0802301105
10.1073/pnas.0802301105 · External reference
10.1007/s12026-010-8179-5
10.1007/s12026-010-8179-5 · External reference
Thrombin cleavage of osteopontin initiates osteopontin’s tumor-promoting activity.
2022 · External reference
10.1002/art.24814
10.1002/art.24814 · External reference
both full-length and protease-cleaved products of osteopontin are elevated in infectious diseases
10.3390/biomedicines9081006 · 2021 · External reference
Thrombin cleavage of osteopontin and the host anti-tumor immune response
10.3390/cancers15133480 · 2023 · External reference
10.1074/jbc.m103608200
10.1074/jbc.m103608200 · External reference
10.1074/jbc.m109.075010
10.1074/jbc.m109.075010 · External reference
10.1073/pnas.0903704106
10.1073/pnas.0903704106 · External reference
10.1038/s41467-024-53023-9
10.1038/s41467-024-53023-9 · External reference
10.1038/s41586-024-08290-3
10.1038/s41586-024-08290-3 · External reference
10.1016/j.intimp.2025.114906
10.1016/j.intimp.2025.114906 · External reference
10.1111/jcmm.18525
10.1111/jcmm.18525 · External reference
10.1016/j.isci.2024.109839
10.1016/j.isci.2024.109839 · External reference
10.1002/jcp.27571
10.1002/jcp.27571 · External reference
10.1016/j.isci.2025.112932
10.1016/j.isci.2025.112932 · External reference
Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis
10.1183/13993003.02441-2018 · 2019 · External reference
10.3892/ijmm.2024.5413
10.3892/ijmm.2024.5413 · External reference
10.1186/s12931-024-02989-7
10.1186/s12931-024-02989-7 · External reference
10.1155/2016/9345495
10.1155/2016/9345495 · External reference
10.1038/ni1415
10.1038/ni1415 · External reference
10.1172/jci17778
10.1172/jci17778 · External reference
10.1074/jbc.m909174199
10.1074/jbc.m909174199 · External reference
10.1016/j.cardiores.2005.01.023
10.1016/j.cardiores.2005.01.023 · External reference
10.1016/s0002-9440(10)64482-3
10.1016/s0002-9440(10)64482-3 · External reference
The role of osteopontin in atherosclerosis and its clinical manifestations (atherosclerotic cardiovascular diseases)-a narrative review
2023 · External reference
10.1161/01.atv.0000074878.29805.d0
10.1161/01.atv.0000074878.29805.d0 · External reference
10.1172/jci31986
10.1172/jci31986 · External reference
10.1016/s0021-9258(18)54932-2
10.1016/s0021-9258(18)54932-2 · External reference
10.1007/bf01621887
10.1007/bf01621887 · External reference
10.1074/jbc.m111.295048
10.1074/jbc.m111.295048 · External reference
10.1186/s13024-015-0059-y
10.1186/s13024-015-0059-y · External reference
10.1038/tp.2016.194
10.1038/tp.2016.194 · External reference
10.1007/s00415-010-5785-z
10.1007/s00415-010-5785-z · External reference
10.12659/msm.905700
10.12659/msm.905700 · External reference
10.1002/ana.22102
10.1002/ana.22102 · External reference
10.1007/s12035-018-0893-3
10.1007/s12035-018-0893-3 · External reference
Osteopontin in the cerebrospinal fluid of patients with severe aneurysmal subarachnoid hemorrhage
10.3390/cells8070695 · 2019 · External reference
10.1002/acn3.52087
10.1002/acn3.52087 · External reference
10.1182/blood-2009-01-197988
10.1182/blood-2009-01-197988 · External reference
10.1111/j.1471-4159.2009.06059.x
10.1111/j.1471-4159.2009.06059.x · External reference
10.1016/j.neuropharm.2018.06.009
10.1016/j.neuropharm.2018.06.009 · External reference
10.1016/j.cca.2019.10.018
10.1016/j.cca.2019.10.018 · External reference
10.1161/strokeaha.113.001574
10.1161/strokeaha.113.001574 · External reference
10.1016/j.brainres.2015.03.015
10.1016/j.brainres.2015.03.015 · External reference
10.31083/j.jin2102062
10.31083/j.jin2102062 · External reference
10.1016/j.expneurol.2023.114585
10.1016/j.expneurol.2023.114585 · External reference
10.1016/j.brainresbull.2025.111607
10.1016/j.brainresbull.2025.111607 · External reference
10.1159/000533953
10.1159/000533953 · External reference
